Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

NCT00282282 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
GVHD

Interventions

DRUG: tacrolimus
DRUG: sirolimus
DRUG: fludarabine
DRUG: busulfex

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]